RHB Retail Research says Sunzen Biotech Berhad may be in the process of extending its rebound after it recently crossed above the 21-day SMA line and holding above the MYR0.165 support level.
In a trading note, the research house says a positive bias may emerge above this point with resistance levels marked at RM0.19 and RM0.215.
A downside breach of RM0.165 would invalidate this positive thesis.